相关实验视频

Updated: Jun 13, 2025

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

HER2成为胃癌患者的新型生存生物标志物:综合分析

Ji Cheng¹, Ming Cai², Guobin Wang²

¹Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277 Jiefang Avenue, Wuhan 430022, China.

Therapeutic advances in medical oncology

|September 16, 2024

概括

胃癌患者的HER2过度表达表明预后更差,无论切除或晚期. 这一发现适用于东亚和非东亚人群,突出显示HER2是关键的生存生物标志物.

科学领域:

在瘤学瘤学.
胃肠病学胃肠病学
分子诊断学分子诊断学

背景情况:

对胃癌而言,抗HER2疗法是常见的,但对HER2过度表达的预后价值尚不确定.
以前的研究缺乏确的证据,原因是HER2评估不一致和患者异质性.

研究的目的:

为了最终评估HER2表达在胃癌中的预后意义.
分析基于HER2状态的生存结果,用于切除和晚期胃癌.

主要方法:

进行了对队列研究的元分析,搜索了多个数据库,直到2022年11月.
包括的研究比较了HER2-阳性和HER2-阴性胃癌患者的整体存活率.
质量评估使用了纽卡斯尔-太华尺度;使用审查主管5.4.4计算了危险比率 (HR).

主要成果:

分析了包括9945名患者在内的30项研究.
HER2阳性切除胃癌的预后明显较差 (HR 1.56,p<0.00001).
HER2阳性晚期胃癌也表明了不利的生存率 (HR 1.70,p=0.001).
亚组分析证实,东亚和非东亚人群的预后较差.

结论:

HER2过度表达是胃癌不良预后的重要指标.
这种预后值适用于可切除和高级阶段,在不同地理区域.
在胃癌患者中,HER2作为一种新且可靠的生存生物标志物.

关键词:

在HER2中,HER2是HER2.胃癌胃癌是一种胃癌.这是一个元分析.幸存率幸存率生存率系统性审查系统性审查

更多相关视频

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...